SEOUL -- SK Biopharmaceuticals will list on Seoul's main stock market on Thursday in a deal raising 959 billion won ($800 million), which would make it South Korea's largest initial public offering in three years.
Pharmaceuticals
SK Biopharm to make stock market debut with $800m IPO
Deal will be largest offering in South Korea in three years and boosts drug sector
Researchers at SK Biopharmaceuticals. The company's IPO is South Korea's largest in three years. (Photo Courtesy of SK Biopharmaceuticals )
Read Next
Latest on Pharmaceuticals
